Previous Close | 27.40 |
Open | 26.60 |
Bid | 26.20 x N/A |
Ask | 26.40 x N/A |
Day's Range | 26.60 - 26.60 |
52 Week Range | 21.40 - 32.80 |
Volume | |
Avg. Volume | 0 |
Market Cap | 1.462B |
Beta (5Y Monthly) | 1.01 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Despite Challenges, Company Shows Promising Growth in Key Areas
Supernus Pharmaceuticals ( NASDAQ:SUPN ) First Quarter 2024 Results Key Financial Results Revenue: US$143.6m (down 6.6...
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript May 8, 2024 Supernus Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to the Supernus Pharmaceuticals First Quarter 2024 Financial Results Conference Call. At this […]